✦ LIBER ✦

Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

✍ Scribed by Porter, Christopher J. H.; Trevaskis, Natalie L.; Charman, William N.

Book ID: 109950202
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 900 KB
Volume: 6
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd2197

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phospholipids and Lipid-Based Formulatio

Phospholipids and Lipid-Based Formulations in Oral Drug Delivery

✍ Gert Fricker; Torsten Kromp; Armin Wendel; Alfred Blume; Jürgen Zirkel; Herbert 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 377 KB

Lipids, lipophilic drugs, and oral drug

Lipids, lipophilic drugs, and oral drug delivery—Some emerging concepts

✍ William N. Charman 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Physical Chemical Considerations of Lipi

Physical Chemical Considerations of Lipid-Based Oral Drug Delivery-Solid Lipid Nanoparticles

✍ Paul M. Bummer 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 55 KB 👁 2 views

Lipid based particulate formulations for

Lipid based particulate formulations for the delivery of antigen

✍ Copland, Melissa J; Rades, Thomas; Davies, Nigel M; Baird, Margaret A 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 575 KB

Logging the delivery of intravenous lipi

Logging the delivery of intravenous lipid emulsion for cocaine and other lipophilic drug overdoses

✍ T. L. Samuels; A. Papadopoulou; J. W. Willers; D. R. Uncles 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Effects of lipophilic components on the

Effects of lipophilic components on the compatibility of lipid-based formulations with hard gelatin capsules

✍ Feng-Jing Chen; Frank M. Etzler; Johanna Ubben; Amy Birch; Li Zhong; Robert Schw 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

The present study investigated the effect of lipophilic components on the compatibility of propylene glycol (PG)-containing lipid-based drug delivery system (LBDDS) formulations with hard gelatin capsules. The presence of a lipophilic active pharmaceutical ingredient (API) (log P approximately 6.1)